Systemic treatment for prostate cancer

This publication has 97 references indexed in Scilit:

• Osteoporosis After Orchiectomy for Prostate Cancer
  Journal of Urology, 1997
• Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1996
• Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
  New England Journal of Medicine, 1995
• Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer
  European Journal Of Cancer, 1993
• Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses
  Quality of Life Research, 1993
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Orchiectomy versus Long‐acting D‐Trp‐6‐LHRH in Advanced Prostatic Cancer
  British Journal of Urology, 1987
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984